What Is Tianeptine?
Tianeptine was developed in France in the 1960s as an antidepressant. It is approved and prescribed as an antidepressant in some European and Latin American countries. It has never been approved by the FDA for any use in the United States.
Its mechanism of action is complex and not fully understood, but research has established that it acts as a mu opioid receptor agonist, meaning it binds to the same receptors in the brain that heroin, oxycodone, and fentanyl bind to. At therapeutic antidepressant doses used in countries where it is approved, this effect is modest. At the doses found in gas station products, which are often dramatically higher than therapeutic ranges, the opioid effect is pronounced.
What Happens When People Take Gas Station Tianeptine Products
At low doses some users report mood elevation, reduced anxiety, and mild euphoria. This is the effect that drives initial use and repeat purchase.
At higher doses the opioid receptor activation becomes more pronounced. Users experience euphoria similar to opioid medications. They also develop tolerance, requiring higher doses to achieve the same effect, and physical dependence.
Physical dependence on tianeptine produces a withdrawal syndrome that includes severe anxiety, agitation, muscle pain, sweating, rapid heart rate, nausea and vomiting, insomnia, and in serious cases seizures. This withdrawal syndrome has been described by emergency physicians and addiction specialists as clinically comparable to opioid withdrawal, and in some respects more severe.
Reported adverse events from tianeptine documented by the FDA and poison control centers include agitation, confusion, drowsiness, nausea, sweating, tachycardia, hypertension, respiratory depression, coma, and death.
Why Is It Being Sold at Gas Stations?
Tianeptine exists in a regulatory gap that is simultaneously straightforward and maddening to explain.
Under the Dietary Supplement Health and Education Act of 1994, a substance can be sold as a dietary supplement if it is not classified as a drug and if it contains ingredients that are, in the language of the law, generally recognized as safe.
Tianeptine has not been formally scheduled as a controlled substance at the federal level as of this writing, which means the DEA has not classified it as a controlled substance. It has not been approved as a drug by the FDA, which means it cannot be sold as a pharmaceutical. But because it has not been formally excluded from the supplement category either, manufacturers have exploited the gap to sell it as a dietary supplement, with labels that make claims about mood, focus, and wellness while saying nothing about opioid receptor activity or addiction potential.
Several states have moved to ban tianeptine specifically. Mississippi and most states have not yet enacted a specific tianeptine ban. This means it remains legally purchasable at gas stations throughout the state today.
Who Is Most at Risk
Tianeptine’s availability at gas stations and online makes it uniquely accessible to populations that are already at elevated risk.
People in recovery from opioid use disorder are at significant risk. Tianeptine’s opioid receptor activity can trigger relapse dynamics and cross dependence in people who have achieved sobriety from opioids. Because it is sold legally and does not appear on standard drug screening panels, it is not caught by most recovery monitoring systems.
Young people who encounter tianeptine products marketed as supplements, mood boosters, or legal highs, and who may not have the clinical context to understand what opioid receptor agonism means in practice, are at risk of initiating opioid like dependence through a product they purchased at a gas station.
People self medicating anxiety or depression may find tianeptine’s initial mood elevating effects genuinely helpful, which is exactly how dependence begins. The problem is not that it does nothing. The problem is what it does to the brain over time.
People taking other central nervous system depressants, including opioid pain medications, benzodiazepines, alcohol, or sleep medications, face the additional risk of combined CNS depression that can cause respiratory failure.
What Standard Drug Tests Miss
One of the most dangerous features of tianeptine from a public health standpoint is that it does not appear on standard urine drug screening panels. Standard opioid panels test for specific opioid compounds, morphine, oxycodone, hydrocodone, buprenorphine, fentanyl. Tianeptine is not on the standard panel.
This means a person actively using tianeptine can pass a workplace drug test, a probation drug test, or a clinical drug screen while actively dependent on a substance that acts like an opioid. It means that emergency room physicians treating a patient in overdose from tianeptine may not immediately recognize the substance involved if they are relying on standard toxicology screens.
What to Do If You or Someone You Know Is Using Tianeptine
If someone you know is using tianeptine products regularly and is trying to stop, do not attempt to manage withdrawal at home without medical support. Tianeptine withdrawal can include seizures and cardiovascular complications that require clinical management.
Contact a healthcare provider or addiction medicine specialist before stopping. The Mississippi Department of Mental Health operates a helpline for substance use concerns at 1 877 210 8513. Poison control, 1 800 222 1222, is available 24 hours a day and can provide guidance on tianeptine exposure.
If someone has taken tianeptine and is unresponsive, breathing abnormally, or cannot be woken up, call 911 immediately. This is a medical emergency.
This article is for general information only and is not a substitute for personalized medical advice. Before starting or changing any medication, including over the counter products and supplements, talk with your pharmacist or physician about your specific situation.
References
- FDAFDA Warns Consumers Not to Use Neptune's Fix or Any Tianeptine ProductSafety alert
- CDCTianeptine Exposures Reported to Poison Control CentersPublic health report
